MIPS program awards $4.7 million for development of technology products

The University of Maryland's Maryland Industrial Partnerships program recently announced that it is awarding $4.7 million to Maryland university researchers to aid 16 local companies in developing important technology products.

The projects team up companies with universities throughout Maryland. Several of the projects focus on medical technologies, such as gene-silencing for cancer treatment, a drug to treat lung fibrosis and a new cardiovascular diagnostic device.

The companies are contributing $3.3 million while MIPS is contributing $1.4 million to the jointly-funded projects. The Maryland Environmental Protection Agency and the Department of Natural Resources also provided funding to support the work of faculty and graduate students for each project.

This round of funding represented the 51st round of MIPS grants. MIPS is in its 26th year, supporting research projects with more than 500 different Maryland companies since 1987.

Other projects for this round of funding include advanced chemical detection, vehicle and sensor technology for inspecting bridges, distributed heating and cooling, a mobile solar milk chiller, fertilizers and soil amendments from fish wastes and other mixtures, an electronic baseball home plate, agricultural stormwater treatment, an advanced oyster seeding system, temperature-detecting gel, and an heirloom tomato juice product system.

Projects from past funding rounds include MedImmune's Synagis, an FDA-approved medication to prevent serious lung infections from respiratory syncytial disease, and WellDoc's mobile diabetes management system.